| Drug Class | Safety Profile | Use in Pregnancy |
|---|---|---|
| Labetalol | Safe; combined α and β blockade; no fetal harm | First-line for acute and chronic management |
| Nifedipine (extended-release) | Safe; no adverse fetal effects | First-line for chronic management |
| Methyldopa | Safe; long track record; slow onset | First-line for chronic management |
| Hydralazine | Safe; used acutely in severe hypertension | Acute management (IV/IM) |
| Atenolol | Relatively safe but associated with IUGR | Not preferred; labetalol preferred |
| ACE inhibitors / ARBs | CONTRAINDICATED | Cause fetal renal dysgenesis, oligohydramnios, death |
| Diuretics | Relative caution (volume depletion) | Avoid unless essential |
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
Daily MCQs, study tips, and topper strategies on Telegram.
Join on Telegram →